We are live on ! Find out more
OMGA

Omega Therapeutics, Inc. Common Stock
OMGA

Delisted

OMGA was delisted on the 24th of February, 2025.

Back to rankings

54 hedge funds and large institutions have $59M invested in Omega Therapeutics, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more call options, than puts

Call options by funds: $33K | Put options by funds: $11K

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

21% less funds holding

Funds holding: 68 → 54 (-14)

44% less capital invested

Capital invested by funds: $105M → $59M (-$45.7M)

53% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 15

70% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 20

Holders
54
Holders Change
-14
Holders Change %
-20.59%
% of All Funds
0.78%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
6
Increased
7
Reduced
15
Closed
20
Calls
$33K
Puts
$11K
Net Calls
+$22K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$551K
2
GAA
Green Alpha Advisors
Colorado
+$99.6K
3
Pathstone Holdings
Pathstone Holdings
New Jersey
+$64.9K
4
RJFSA
Raymond James Financial Services Advisors
Florida
+$33.9K
5
FIM
Freedom Investment Management
Connecticut
+$20K

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$2.74M
2
Citadel Advisors
Citadel Advisors
Florida
-$1.64M
3
Jane Street
Jane Street
New York
-$442K
4
Goldman Sachs
Goldman Sachs
New York
-$394K
5
Millennium Management
Millennium Management
New York
-$348K
Name Holding Trade Value Shares
Change 		Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$35.7M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$7.4M -$286K -179,912 -3%
HP
3
Harbourvest Partners
Massachusetts
$4.28M – – –
State of Wisconsin Investment Board
4
State of Wisconsin Investment Board
Wisconsin
$2.27M – – –
SL
5
Siren LLC
Connecticut
$1.61M +$2.11M +1,323,530 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.36M – – –
BOCH
7
Blue Owl Capital Holdings
New York
$1.29M – – –
6CM
8
683 Capital Management
New York
$732K – – –
Millennium Management
9
Millennium Management
New York
$653K -$348K -218,607 -29%
Renaissance Technologies
10
Renaissance Technologies
New York
$579K +$551K +346,200 +270%
7IH
11
72 Investment Holdings
Connecticut
$431K – – –
PIM
12
Platinum Investment Management
Australia
$423K – – –
SOMRS
13
State of Michigan Retirement System
Michigan
$383K – – –
BlackRock
14
BlackRock
New York
$331K -$147K -92,302 -25%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$282K -$9.55K -6,000 -3%
BCM
16
Bridgeway Capital Management
Texas
$145K – – –
Point72 Asset Management
17
Point72 Asset Management
Connecticut
$142K – – –
State Street
18
State Street
Massachusetts
$116K – – –
LCAM
19
Long Corridor Asset Management
Hong Kong
$104K – – –
Two Sigma Investments
20
Two Sigma Investments
New York
$98.9K +$11.7K +7,369 +10%
RC
21
RBF Capital
California
$77.9K -$3.82K -2,400 -4%
GAA
22
Green Alpha Advisors
Colorado
$76.3K +$99.6K +62,561 New
RJFSA
23
Raymond James Financial Services Advisors
Florida
$72.6K +$33.9K +21,307 +56%
Morgan Stanley
24
Morgan Stanley
New York
$53.7K -$79.6K -50,016 -53%
Pathstone Holdings
25
Pathstone Holdings
New Jersey
$49.8K +$64.9K +40,789 New
1
2 3

OMGA Hedge Fund Activity: Q3 2024 in Review

54 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Omega Therapeutics, Inc. Common Stock (OMGA) for Q3 2024, worth a combined $59M — down 44% from $105M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of OMGA and 6 opened new positions — a net loss of 14 holders — while 15 trimmed existing stakes and 7 added.

The largest buyer was Renaissance Technologies, adding an estimated $551K. The largest seller was Artal Group, exiting entirely with an estimated $2.74M sold.

  • 54 institutional investors held Omega Therapeutics, Inc. Common Stock (OMGA) as of Q3 2024, down from 68 in Q2 2024.
  • Funds reported $59M of Omega Therapeutics, Inc. Common Stock stock for Q3 2024, down 44% quarter-over-quarter.
  • 6 funds opened new Omega Therapeutics, Inc. Common Stock positions in Q3 2024 and 20 closed out, a net change of -14 holders.
  • The largest Omega Therapeutics, Inc. Common Stock buyer in Q3 2024 was Renaissance Technologies, an estimated $551K added.
  • The largest Omega Therapeutics, Inc. Common Stock seller in Q3 2024 was Artal Group, an estimated $2.74M sold.

Based on aggregated 13F filings for Q3 2024.